'It made me feel part of the team, having my homework to do' - women and specialist nurse experiences of remote follow-up after ovarian cancer treatment: a qualitative interview study

Support Care Cancer. 2022 Dec 13;31(1):2. doi: 10.1007/s00520-022-07470-z.

Abstract

Purpose: Ovarian cancer patients require monitoring for relapse post-treatment, and alternative follow-up pathways are increasing, which require in-depth exploration to ensure acceptability and inform implementation. This study aimed to explore women and specialist nurses' experiences of participating in a feasibility study of an electronic patient-reported outcome (ePRO) follow-up pathway after ovarian cancer treatment.

Methods: The feasibility study incorporated an ePRO questionnaire, blood test and telephone consultation with a specialist nurse, instead of face-to-face hospital visits. All women and the nurses involved were invited to take part in nested semi-structured interviews. Interviews were recorded and transcripts analysed using framework analysis.

Results: Twenty interviews were conducted (16 out of 24 women who took part in the feasibility study and all 4 nurses). Four themes were identified: (1) readiness and motivators, (2) practicalities and logistics, (3) personal impact and (4) future role. An overarching theme highlighted how women strived to seek reassurance and gain confidence. Most women and nurses were positive about the ePRO pathway and would happily continue using it.

Conclusion: This work provides invaluable insight into the experiences of women on remote ePRO follow-up post-treatment. Important logistic and implementation issues were identified, which should inform future large-scale work to introduce and evaluate remote ePRO methods in cancer follow-up. This work highlights the key factors influencing women's readiness and acceptability of an ePRO pathway, and how services should be carefully designed to ensure patients feel reassured and confident post-treatment. Furthermore, it highlights that flexibility and patient preference should be considered in remote service delivery.

Trial registration: ClinicalTrials.gov ID: NCT02847715 (first registered 19 May 2016).

Keywords: Electronic patient-reported outcome measures; Follow-up; Nurse-led telephone consultations; Ovarian cancer; Qualitative.

MeSH terms

  • Female
  • Follow-Up Studies
  • Humans
  • Neoplasm Recurrence, Local
  • Nurses*
  • Ovarian Neoplasms* / therapy
  • Qualitative Research
  • Referral and Consultation
  • Telephone

Associated data

  • ClinicalTrials.gov/NCT02847715